Growth Metrics

Emergent BioSolutions (EBS) Current Deferred Tax Assets: 2010-2015

Historic Current Deferred Tax Assets for Emergent BioSolutions (EBS) over the last 4 years, with Sep 2015 value amounting to $1.5 million.

  • Emergent BioSolutions' Current Deferred Tax Assets was N/A to $1.5 million in Q3 2015 from the same period last year, while for Sep 2015 it was $1.5 million, marking a year-over-year change of. This contributed to the annual value of $1.7 million for FY2014, which is N/A change from last year.
  • Latest data reveals that Emergent BioSolutions reported Current Deferred Tax Assets of $1.5 million as of Q3 2015, which was down 0.00% from $1.5 million recorded in Q2 2015.
  • In the past 5 years, Emergent BioSolutions' Current Deferred Tax Assets ranged from a high of $7.2 million in Q3 2011 and a low of $327,000 during Q3 2012.
  • Its 3-year average for Current Deferred Tax Assets is $1.4 million, with a median of $1.5 million in 2015.
  • Its Current Deferred Tax Assets has fluctuated over the past 5 years, first slumped by 95.46% in 2012, then skyrocketed by 286.54% in 2013.
  • Quarterly analysis of 5 years shows Emergent BioSolutions' Current Deferred Tax Assets stood at $1.7 million in 2011, then decreased by 27.15% to $1.3 million in 2012, then soared by 286.54% to $1.3 million in 2013, then reached $1.7 million in 2014, then reached $1.5 million in 2015.
  • Its Current Deferred Tax Assets was $1.5 million in Q3 2015, compared to $1.5 million in Q2 2015 and $1.7 million in Q1 2015.